Inflammatory subtypes in cough-variant asthma: Association with maintenance doses of inhaled corticosteroids

Chest

Volumn 138, Issue 6, 2010, Pages 1418-1425

  Matsuoka, Hirofumi ^a   Niimi, Akio ^a   Matsumoto, Hisako ^a   Takemura, Masaya ^b   Ueda, Tetsuya ^c   Yamaguchi, Masafumi ^a   Jinnai, Makiko ^a   Inoue, Hideki ^a   Ito, Isao ^a   Chin, Kazuo ^a   Mishima, Michiaki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Kitano Hospital   (Japan)

^c SAISEIKAI NAKATSU HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; INTERLEUKIN 8; LEUKOCYTE ELASTASE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; THEOPHYLLINE;

ADULT; AGE DISTRIBUTION; ARTICLE; ASTHMA; CORTICOSTEROID THERAPY; COUGH VARIANT ASTHMA; COUGHING; DRUG DOSE REDUCTION; EOSINOPHIL COUNT; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GRANULOCYTE; HUMAN; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; SPUTUM ANALYSIS; SPUTUM LEVEL; TREATMENT OUTCOME;

EID: 78649890485     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-0132     Document Type: Article

References (51)

1. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323(15):1033-1039.
2. Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M, Djukanović R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med. 2000;161(1):9-16.
3. Gibson PG, Fujimura M, Niimi A. Eosinophilic bronchitis: clinical manifestations and implications for treatment. Thorax. 2002;57(2):178-182.
4. Fahy JV. Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. Proc Am Thorac Soc. 2009;6(3):256-259.
5. Simpson JL, Phipps S, Gibson PG. Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis. Pharmacol Ther. 2009;124(1):86-95.
6. Ordoñez CL, Shaughnessy TE, Matthay MA, Fahy JV. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: clinical and biologic significance. Am J Respir Crit Care Med. 2000;161(4 Pt 1):1185-1190.
7. Sur S, Crotty TB, Kephart GM, et al. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis. 1993;148(3):713-719.
8. Wenzel SE, Schwartz LB, Langmack EL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med. 1999;160(3):1001-1008.
9. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1532-1539.
10. Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest. 2001;119(5):1329-1336.
11. Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax. 2002;57(10):875-879.
12. Berry MA, Morgan A, Shaw DE, et al. Pathological features and inhaled corticosteroid response of eosinophilic and noneosinophilic asthma. Thorax. 2007;62(12):1043-1049.
13. Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11(1):54-61.
14. Simpson JL, Grissell TV, Douwes J, Scott RJ, Boyle MJ, Gibson PG. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax. 2007;62(3):211-218.
15. Haldar P, Pavord ID. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol. 2007;119(5):1043-1052., quiz 1053-1054.
16. Matsumoto H, Niimi A, Minakuchi M, Izumi T. Serum eosinophil cationic protein levels measured during exacerbation of asthma: characteristics of patients with low titres. Clin Exp Allergy. 2001;31(4):637-643.
17. Corrao WM, Braman SS, Irwin RS. Chronic cough as the sole presenting manifestation of bronchial asthma. N Engl J Med. 1979;300(12):633-637.
18. Niimi A, Matsumoto H, Mishima M. Eosinophilic airway disorders associated with chronic cough. Pulm Pharmacol Ther. 2009;22(2):114-120.
19. Niimi A. Geography and cough aetiology. Pulm Pharmacol Ther. 2007;20(4):383-387.
20. Takemura M, Niimi A, Matsumoto H, et al. Atopic features of cough variant asthma and classic asthma with wheezing. Clin Exp Allergy. 2007;37(12):1833- 1839.
21. Niimi A, Matsumoto H, Minakuchi M, Kitaichi M, Amitani R. Airway remodelling in cough-variant asthma. Lancet. 2000;356(9229):564-565.
22. Niimi A, Torrego A, Nicholson AG, Cosio BG, Oates TB, Chung KF. Nature of airway inflammation and remodeling in chronic cough. J Allergy Clin Immunol. 2005;116(3):565-570.
23. Fujimura M, Songür N, Kamio Y, Matsuda T. Detection of eosinophils in hypertonic saline-induced sputum in patients with chronic nonproductive cough. J Asthma. 1997;34(2):119-126.
24. Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F. Eosinophilic inflammation in cough variant asthma. Eur Respir J. 1998;11(5):1064-1069.
25. Kim CK, Kim JT, Kang H, Yoo Y, Koh YY. Sputum eosinophilia in cough-variant asthma as a predictor of the subsequent development of classic asthma. Clin Exp Allergy. 2003;33(10):1409-1414.
26. Committee for the Japanese Respiratory Society Guidelines for Management of Cough; Kohno S, Ishida T, Uchida Y, et al. The Japanese Respiratory Society guidelines for management of cough. Respirology. 2006;11(Suppl 4):S135-S186.
27. Matsuoka H, Niimi A, Matsumoto H, et al. Specific IgE response to trichophyton and asthma severity. Chest. 2009;135(4):898-903.
28. Takishima T, Hida W, Sasaki H, Suzuki S, Sasaki T. Directwriting recorder of the dose-response curves of the airway to methacholine. Clinical application. Chest. 1981;80(5):600-606.
29. Niimi A, Matsumoto H, Takemura M, Ueda T, Chin K, Mishima M. Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am J Respir Crit Care Med. 2003;168(8):983-988.
30. National Institute of Health/National Heart, Lung, and Blood Institute. Global Strategy for Asthma Management and Prevention. Bethesda, MD: National Institute of Health/National Heart, Lung, and Blood Institute; 2006. Publication #02-3659.
31. Selroos O, Löfroos AB, Pietinalho A, Riska H. Asthma control and steroid doses 5 years after early or delayed introduction of inhaled corticosteroids in asthma: a real-life study. Respir Med. 2004;98(3):254-262.
32. Takemura M, Niimi A, Minakuchi M, et al. Bronchial dilatation in asthma: relation to clinical and sputum indices. Chest. 2004;125(4):1352-1358.
33. Fahy JV, Liu J, Wong H, Boushey HA. Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation . J Allergy Clin Immunol. 1994;93(6):1031-1039.
34. Matsuoka H, Niimi A, Matsumoto H, et al. Patients' characteristics associated with unsuccessful sputum induction in asthma. J Allergy Clin Immunol. 2008;121(3):774-776.
35. Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med. 1997;156(3 Pt 1):737-743.
36. European Network for Understanding Mechanisms of Severe Asthma. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J. 2003;22(3):470-477.
37. Vignola AM, Bonanno A, Mirabella A, et al. Increased levels of elastase and alpha1-antitrypsin in sputum of asthmatic patients. Am J Respir Crit Care Med. 1998;157(2):505-511.
38. Shannon J, Ernst P, Yamauchi Y, et al. Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest. 2008;133(2):420-426.
39. Woodruff PG, Khashayar R, Lazarus SC, et al. Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. J Allergy Clin Immunol. 2001;108(5):753-758.
40. Kikuchi S, Nagata M, Kikuchi I, Hagiwara K, Kanazawa M. Association between neutrophilic and eosinophilic inflammation in patients with severe persistent asthma. Int Arch Allergy Immunol. 2005;137(Suppl 1):7-11. (Pubitemid 40868767)
41. Kita H, Abu-Ghazaleh RI, Sur S, Gleich GJ. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils. J Immunol. 1995;154(9):4749-4758.
42. Page SM, Gleich GJ, Roebuck KA, Thomas LL. Stimulation of neutrophil interleukin-8 production by eosinophil granule major basic protein. Am J Respir Cell Mol Biol. 1999;21(2):230-237.
43. Haskell MD, Moy JN, Gleich GJ, Thomas LL. Analysis of signaling events associated with activation of neutrophil superoxide anion production by eosinophil granule major basic protein. Blood. 1995;86(12):4627-4637.
44. Shenoy NG, Gleich GJ, Thomas LL. Eosinophil major basic protein stimulates neutrophil superoxide production by a class IA phosphoinositide 3-kinase and protein kinase C-zeta-dependent pathway. J Immunol. 2003;171(7):3734-3741.
45. Erger RA, Casale TB. Interleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium. Am J Physiol. 1995;268(1 Pt 1):L117-L122.
46. Park HS, Jung KS, Shute J, Roberts K, Holgate ST, Djukanović R. Allergen-induced release of GM-CSF and IL-8 in vitro by nasal polyp tissue from atopic subjects prolongs eosinophil survival. Eur Respir J. 1997;10(7):1476- 1482.
47. Kikuchi I, Kikuchi S, Kobayashi T, et al. Eosinophil transbasement membrane migration induced by interleukin-8 and neutrophils. Am J Respir Cell Mol Biol. 2006;34(6):760-765.
48. Nadif R, Siroux V, Oryszczyn M-P, et al;Epidemiological study on the Genetics and Environment of Asthma (EGEA). Heterogeneity of asthma according to blood inflammatory patterns. Thorax. 2009;64(5):374-380.
49. Simpson JL, Powell H, Boyle MJ, Scott RJ, Gibson PG. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med. 2008;177(2):148-155.
50. Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. The effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax. 2010;65(5):384-390.
51. Hara J, Fujimura M, Ueda A, et al. Effect of pressure stress applied to the airway on cough-reflex sensitivity in Guinea pigs. Am J Respir Crit Care Med. 2008;177(6):585-592.